MedPath

Safety testing of cosmetic product by patch test on subjects with sensitive ski

Not Applicable
Completed
Registration Number
CTRI/2018/07/014697
Lead Sponsor
ITC Life Sciences Technology Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
35
Inclusion Criteria

1. Healthy male and female subjects in the age group of 18-55 years(both age inclusive)

2. Subjects in good general health

3. Subjects with Fitzpatrick skin type III to V

4. Subjects scoring greater than 30 for Section 2- Sensitive v/s Resistant skin in modified Dr. Baumannâ??s skin type questionnaire

5. Subject identified to have sensitive skin basis dermatologistâ??s assessment of skin with fine texture and closeness of blood vessels

to the surface

6. Subjects willing to give a voluntary written informed consent

7. Subjects willing to maintain the test patches in designated positions for 24 hours

8. Subjects having not participated in a similar investigation in the past eight weeks

9. Subjects willing to come for regular follow up visits

10. Subjects ready to follow instructions during the study period

11. Subjects without any open wounds, cuts, abrasions, irritation symptoms

Exclusion Criteria

1. Subjects with a present condition of allergic response to any cosmetic product

2. Subjects under chronic medication (e.g. Antihistamines, Antifungals, Corticosteroids,

topical Steroids, etc.) that might influence the outcome of the study

3. Subjects who are pregnant or nursing (as confirmed by Urine pregnancy test for the

determination of Pregnancy)

4. Subjects with cutaneous disease that could interfere with the study results

5. Subjects with chronic illness that may influence the cutaneous state or any other

illness including Diabetes, liver disease, HIV or any other serious medical illness

6. Subjects participating in any other cosmetic or therapeutic trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety assessment of investigational products for <br/ ><br>irritation potential using Draize scaleTimepoint: Safety assessment of investigational products for <br/ ><br>irritation potential using Draize scale done on 0 <br/ ><br>hour after patch removal, 24 hours after patch removal and 7 days post patch removal
Secondary Outcome Measures
NameTimeMethod
ot ApplicableTimepoint: Not Applicable
© Copyright 2025. All Rights Reserved by MedPath